DR. MARK ALAN MITCHNICK, MD
Medical Practice at Three Mile Harbor Dr, East Hampton, NY

License number
New York A180264
Category
Medical Practice
Type
Pediatrics
Address
Address
80 Three Mile Harbor Dr, East Hampton, NY 11937
Phone
(631) 329-3255

Professional information

Mark Mitchnick Photo 1

Pharmaceutical Solutions And Method For Solublilizing Therapeutic Agents

US Patent:
2011003, Feb 17, 2011
Filed:
Mar 27, 2009
Appl. No.:
12/933701
Inventors:
Garry Thomas Gwozdz - Jim Thorpe PA, US
Andrew Loxley - Philadelphia PA, US
Mark Mitchnick - East Hampton NY, US
International Classification:
A61K 9/00, A61K 31/5513, A61K 38/00, A61K 31/7052, A61K 31/573, A61K 31/565, A61K 31/436, A61K 31/337, A61K 38/12
US Classification:
424400, 514221, 514 11, 514 52, 514180, 514182, 514291, 514449, 514 211
Abstract:
Pharmaceutical solutions containing hydrophobic or lipophilic therapeutic agents and methods for producing the same are provided. Pharmaceutical solutions of the invention are produced by dissolving the therapeutic agent in one or more tocopherols or tocotrienols and one or more alcohols or glycols. These solutions are used to produce pharmaceutical compositions.


Mark Mitchnick Photo 2

Devices And Methods For Analysis Of Samples With Depletion Of Analyte Content

US Patent:
2009008, Apr 2, 2009
Filed:
Oct 1, 2007
Appl. No.:
11/865555
Inventors:
Peter Wagner - Belmont CA, US
Frank Zaugg - Belmont CA, US
Mark Mitchnick - East Hampton NY, US
Assignee:
Zyomyx, Inc. - Hayward CA
International Classification:
G01N 33/543, B01J 19/00, C12M 1/00, G01N 21/00, G01N 33/00
US Classification:
436518, 422 681, 4352871, 422 8205, 436 63
Abstract:
A system and method for determining the presence and/or concentration of one or more analytes in a sample that comprises a fluid, the system comprising a solid substrate comprising a sample inlet or inlets and one or more analyte determination flow paths, each analyte determination flow path comprising a defined beginning and a defined terminus and comprising at least one capture zone containing a capture agent for an analyte, the capture agent or agents being immobilized along a portion of the flow path or paths, the flow path or paths being designed so that the one or more analytes are depleted from the sample and bound in a non-linear manner to the portion of the flow path or paths containing immobilized capture agent or agents, producing an analyte depletion end region for each analyte between the beginning and the terminus of the analyte determination flow path.


Mark Mitchnick Photo 3

Physiologic Database And System For Population Modeling And Method Of Population Modeling

US Patent:
2011005, Mar 3, 2011
Filed:
Aug 26, 2010
Appl. No.:
12/869586
Inventors:
P. Alexander DERCHAK - Oxnard CA, US
Mark Mitchnick - East Hampton NY, US
Assignee:
adidas AG, World of Sports - Herzogenaurach
International Classification:
A61B 5/04, G06F 17/30
US Classification:
600388, 707737
Abstract:
The present invention provides apparatuses and methods for creating a physiologic database or library that can be indexed to at least health, disease, patient characteristics, and acute medical crises or other dangerous condition. The present invention also provides apparatuses and methods for creating an athletic performance database or library. The database can be structured and continuous/pseudo-continuous modeling statistics applied to provide novel insight into performance and progress of an athlete or group of athletes, as well as standing relative to other athletes, or to provide novel insight into the natural history of disease and the response to treatment, and ultimately to improve care delivery.


Mark Mitchnick Photo 4

Methods And Devices For Detecting Binding Events Via Zeta-Potential And Pharmacologically Active Compounds And Delivery Systems Identified Thereby

US Patent:
2010008, Apr 8, 2010
Filed:
Apr 4, 2008
Appl. No.:
12/593616
Inventors:
Mark Mitchnick - East Hampton NY, US
Andrew Loxley - Philadelphia PA, US
David Fairhurst - Congers NY, US
Peter Wagner - Menlo Park CA, US
International Classification:
A61K 9/14, G01N 33/566, G01N 30/96, A61K 38/00, A61K 31/7088, A61K 31/70, A61K 38/16
US Classification:
424489, 436501, 422 69, 514 2, 514 44 R, 514 23, 514 8
Abstract:
Methods, devices and arrays for measuring a change in zeta-potential of a surface indicative of a binding event are provided. Pharmacologically active compounds and delivery systems for active pharmaceutical ingredients determined to be pharmacologically active or optimized for pharmacological activity or determined to be useful for delivery of the active pharmaceutical ingredient to a target via measurement of a change in zeta-potential of the compound, ingredient or delivery system are also provided.


Mark Mitchnick Photo 5

Cosmetic Compositions Containing Hydrophobized Zinc Oxide

US Patent:
5536492, Jul 16, 1996
Filed:
Oct 30, 1995
Appl. No.:
8/549873
Inventors:
Mark Mitchnick - East Hampton NY
Anthony J. O'Lenick - Lilburn GA
Assignee:
Siltech Inc. - Norcross GA
SunSmart Inc. - Wainscott NY
International Classification:
A61K 742
US Classification:
424 59
Abstract:
A process for protecting the skin from ultra violet rays of the sun which comprises contacting the skin with an effective protecting concentration of a hydrophobized zinc oxide, is disclosed. The zinc oxide is hydrophobic, non-reactive, and not affected by water.


Mark Mitchnick Photo 6

Aerosol Dispersions Of Particles With Active Pharmaceutical Ingredients

US Patent:
8540969, Sep 24, 2013
Filed:
Apr 18, 2008
Appl. No.:
12/596508
Inventors:
Andrew Loxley - Philadelphia PA, US
Ismar Dizdarevic - Nutley NJ, US
Mark Mitchnick - East Hampton NY, US
Assignee:
Particle Sciences, Inc. - Bethlehem PA
International Classification:
A61K 9/12, A61K 9/127, A61K 9/133, A61K 9/14
US Classification:
424 45, 424489, 424450
Abstract:
Aerosols containing a plurality of aqueous droplets, each droplet containing on average at least one essentially-neutral particle sized to fit within the droplet are provided. Aerosols wherein an active pharmaceutical ingredient is attached to, or otherwise incorporated in the essentially neutral particles are also provided. Methods for administering an active pharmaceutical ingredient to a subject in need thereof via inhalation of these aerosols, preferably via nebulizer, are also provided.


Mark Mitchnick Photo 7

Apparatus And Methods For Monitoring Subjects

US Patent:
2006008, Apr 20, 2006
Filed:
Oct 14, 2004
Appl. No.:
10/965010
Inventors:
Mark Mitchnick - East Hampton NY, US
International Classification:
A61B 5/00, A61B 5/103
US Classification:
600301000, 600549000, 128903000, 600595000, 600591000, 600573000
Abstract:
This invention provides a device, and method and system for its use, for monitoring participants in clinical trials so that participant self-reporting, which is known to be notoriously inaccurate, can be minimized or eliminated. In preferred embodiments, the device is self-contained and self-powered, resides on or in a body cavity of the participant, collects data monitoring medically relevant aspects of the participant's behavior and of the local device environment, and stores data in a memory on-board the device. An accompanying external station reads stored data and prepares it for use. Devices may include electrically-active sensors and non-electrical active sampling sensors. A preferred embodiment of the device is in clinical trials of microbicides inhibiting transmission of the HIV virus.


Mark Mitchnick Photo 8

Delivery Devices Containing Encapsulated And/Or Particle-Bound Active Pharmaceutical Ingredients

US Patent:
2010003, Feb 11, 2010
Filed:
Feb 12, 2008
Appl. No.:
12/525568
Inventors:
David Fairhurst - Congers NY, US
Garry Thomas Gwozdz - Nazareth PA, US
Mark Mitchnick - East Hampton NY, US
Abhijit Gokhale - Allentown PA, US
Andrew Loxley - Philadelphia PA, US
International Classification:
A61F 2/00, A61K 9/107, A61F 6/14
US Classification:
424423, 424484, 424432
Abstract:
Delivery devices of a degradable or nondegradable biocompatible matrix with one or more encapsulated active pharmaceutical ingredients or one or more particle-bound active pharmaceutical ingredients dispersed in the matrix are provided. Also provided are methods for delivering an active pharmaceutical ingredient to a subject with these delivery devices. Modified vaginal rings are also provided as well as surface coatings for delivery devices which minimize bio-interaction of the coated delivery devices.


Mark Mitchnick Photo 9

Biodegradable Intravaginal Devices For Delivery Of Therapeutics

US Patent:
2010016, Jul 1, 2010
Filed:
Jan 22, 2008
Appl. No.:
12/523383
Inventors:
Patrick F. Kiser - Salt Lake City UT, US
Patrick Tresco - Sandy UT, US
Mark Mitchnick - East Hampton NY, US
Kavita Gupta - Salt Lake City UT, US
Hyder Aliyar - Salt Lake City UT, US
Assignee:
University of Uath Research Foundation - Salt Lake City UT
International Classification:
A61F 2/00, A61F 6/06, A61K 31/675, A61P 31/18, A61M 31/00, A61P 13/02, A61P 15/00, A61P 3/10
US Classification:
424426, 128832, 424430, 514 81, 604500, 604285
Abstract:
The present disclosure relates to biodegradable intravaginal rings for the delivery of therapeutic or prophylactic agent, inter alia, antiviral agents. The present disclosure further relates to biodegradable polyurethanes which will allow therapeutic/prophylactic agents to be released in a controlled manner that will not degrade when in use, but will degrade upon disposal.


Mark Mitchnick Photo 10

Administration Of Benzodiazepine Compositions

US Patent:
2009025, Oct 15, 2009
Filed:
Mar 27, 2009
Appl. No.:
12/413439
Inventors:
Steve Cartt - Union City CA, US
David Medeiros - South San Francisco CA, US
Gary Thomas Gwozdz - Nazareth PA, US
Andrew Loxley - Philadelphia PA, US
Mark Mitchnick - East Hampton NY, US
David F. Hale - San Diego CA, US
Assignee:
HALE BIOPHARMA VENTURES, LLC - Encinitas CA
International Classification:
A61K 31/5513
US Classification:
514221
Abstract:
The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.